Accès gratuit
Pré-publication électronique
Dans une revue
Rev. Méd. Périnat.
Section Article Original / Original Article
DOI https://doi.org/10.3166/rmp-2020-0085
Publié en ligne 13 juillet 2020
  • Lo YM, Corbetta N, Chamberlain PF, et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet Lond Engl 350:485–7 [CrossRef] [PubMed] [Google Scholar]
  • Gil MM, Accurti V, Santacruz B, et al (2017) Analysis of cellfree DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 50:302–14 [CrossRef] [PubMed] [Google Scholar]
  • Fiorentino F, Bono S, Pizzuti F, et al (2017) The clinical utility of genome-wide non-invasive prenatal screening. Prenat Diagn 37:593–601 [Google Scholar]
  • Brison N, Neofytou M, Dehaspe L, et al (2018) Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing. Prenat Diagn 38:258–66 [Google Scholar]
  • Gil MM, Galeva S, Jani J, et al (2019) Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis. Ultrasound Obstet Gynecol 53:734–42 [PubMed] [Google Scholar]
  • Alexander S, Audibert F, Barkat A, et al (2016) Dépistage prénatal non invasif de la trisomie 21 sur ADN foetal circulant : quelles pratiques dans cinq pays francophones ? Rev Med Perinat 8:31–8 [CrossRef] [Google Scholar]
  • Gadsbøll K, Petersen OB, Gatinois V, et al (2020) Current use of non-invasive prenatal testing in Europe, Australia and the USA: a graphical presentation. Acta Obstet Gynecol Scand 99(6) :722–30 [Google Scholar]
  • BeSHG Prenatal Committee (2020) Clinical and societal impact of national publicly funded first-tier non-invasive prenatal testing (submitted) [Google Scholar]
  • de Wergifosse S, Bevilacqua E, Mezela I, et al (2019) Cell-free DNA analysis in maternal blood: comparing genome-wide versus targeted approach as a first-line screening test. J Matern Fetal Neonatal Med 13:1–10 [Google Scholar]
  • https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/avis_66_nipt_fr.pdf [Google Scholar]
  • http://www.beshg.be/download/guidelines/BELGIAN_GUIDELINES_FOR_MANAGING_INCIDENTAL_FINDINGS_DETECTED_BY_NIPT_20190905.pdf [Google Scholar]
  • Toutain J, Goutte-Gattat D, Horovitz J, Saura R (2018) Confined placental mosaicism revisited: impact on pregnancy characteristics and outcome. PloS One 13:e0195905 [CrossRef] [PubMed] [Google Scholar]
  • Vanakker O, Vilain C, Janssens K, et al (2014) Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges. Eur J Med Genet 57:151–6 [Google Scholar]
  • Lenaerts L, Jatsenko T, Amant F, Robert Vermeesch J (2019) Non-invasive prenatal testing and detection of occult maternal malignancies. Clin Chem 65:1484–6 [CrossRef] [PubMed] [Google Scholar]
  • Vandenberghe P, Wlodarska I, Tousseyn T, et al (2015) Noninvasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin’s lymphoma by sequencing of circulating cell-free DNA: a technical proof of principle study. Lancet Haematol 2:e55‒e65 [CrossRef] [PubMed] [Google Scholar]
  • Amant F, Verheecke M, Wlodarska I, et al (2015) Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol 1:814–9 [CrossRef] [PubMed] [Google Scholar]
  • Brison N, Storms J, Villela D, et al (2019) Maternal copy-number variations in the DMD gene as secondary findings in noninvasive prenatal screening. Genet Med 21(12) :2774–80 [CrossRef] [PubMed] [Google Scholar]
  • Wapner RJ, Martin CL, Levy B, et al (2012) Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 367:2175–84 [Google Scholar]
  • de Wit MC, Srebniak MI, Govaerts LC, et al (2014) Additional value of prenatal genomic array testing in fetuses with isolated structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature. Ultrasound Obstet Gynecol 43:139–46 [CrossRef] [PubMed] [Google Scholar]
  • Hillman SC, McMullan DJ, Hall G, et al (2013) Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 41:610‒20 [CrossRef] [PubMed] [Google Scholar]
  • Hillman SC, Pretlove S, Coomarasamy A, et al (2011) Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 37:6–14 [CrossRef] [PubMed] [Google Scholar]
  • Oneda B, Rauch A (2017) Microarrays in prenatal diagnosis. Best Pract Res Clin Obstet Gynaecol 42:53–63 [CrossRef] [PubMed] [Google Scholar]
  • Brady PD, Delle Chiaie B, Christenhusz G, et al (2014) A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genet Med 16:469–76 [CrossRef] [PubMed] [Google Scholar]
  • Srebniak MI, Diderich KE, Joosten M, et al (2016) Prenatal SNP array testing in 1,000 fetuses with ultrasound anomalies: causative, unexpected and susceptibility CNVs. Eur J Hum Genet 24:645–51 [Google Scholar]
  • Petrovski S, Aggarwal V, Giordano JL, et al (2019) Wholeexome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet 393:758–67 [CrossRef] [PubMed] [Google Scholar]
  • Lord J, McMullan DJ, Eberhardt RY, et al (2019) Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study. Lancet 393:747–57 [CrossRef] [PubMed] [Google Scholar]
  • Green RC, Berg JS, Grody WW, et al (2013) ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. Genet Med 15:565–74 [CrossRef] [PubMed] [Google Scholar]
  • Choi H, Van Riper M, Thoyre S (2012) Decision-making following a prenatal diagnosis of down syndrome: an integrative review. J Midwifery Womens Health 57:156–64 [CrossRef] [PubMed] [Google Scholar]
  • Crombag NM, Page-Christiaens GC, Skotko BG, de Graaf G (2020) Receiving the news of Down syndrome in the era of prenatal testing. Am J Med Genet A 182:374–85 [CrossRef] [PubMed] [Google Scholar]
  • Donner C, Désir J (2019) Le dépistage prénatal non invasif (DPNI) : état des lieux. Volume 40 — no 2 — Avril, pp 65‒128 [Google Scholar]
  • Muys J, Blaumeiser B, Jacquemyn Y, et al (2018) The Belgian MicroArray Prenatal (BEMAPRE) database: a systematic nationwide repository of fetal genomic aberrations. Prenat Diagn 38:1120–8 [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.